Sign in to view content

Low-Dose Atropine 0.01% Drops for Symptomatic Vitreous Floaters: A Noninvasive, Safe, and Effective Therapeutic Option

Mohsin H. Ali, MD

Video
Published 2025

Related

Real-World Visual Outcomes After YAG Vitreolysis for Vitreous Opacities (VOYAGE)
Netan Choudhry, MD, FRCS(C) FASRS
Updates from the Field
2020
Assessment of Central Subfield Thickness Fluctuations and Impact on Vision in Archway Phase 3 Trial of the Port Delivery System With Ranibizumab (PDS)
Chirag D. Jhaveri, MD, FASRS
Annual Meeting Talks
2021
Medical Treatment of Macular Holes With Drops
Dimitra Skondra, MD,PhD
On Demand Cases, Courses, and Papers
2019

Category: Pharmacology

See more